To give accurate information is our responsibly.
AstraZeneca has identified an additional novel target for its drug development portfolio for idiopathic pulmonary fibrosis (IPF), allowing BenevolentAI, a leading clinical-stage AI-enabled drug discovery …
NanoViricides, Inc., a frontrunner in the development of antiviral therapies based on a novel platform of nanomedicines has reported to have begun drug development to …
The US Food and Drug Administration (FDA) recently released draught guidance documents on drug development for ulcerative colitis (UC) and Crohn’s disease, which include clinical …
A recent announcement by Mumbai based drug manufacturer, Lupin states that they have bagged approval from USFDA – the United States Food and Drug Administration, …
Pfizer, which developed the mRNA-based vaccination against the novel coronavirus, announced the establishment of a worldwide drug development center in India to facilitate advanced research …
by 
